ClinConnect ClinConnect Logo
Search / Trial NCT05697939

3D Body Surface Modeling for Scoliosis Monitoring

Launched by STANFORD UNIVERSITY · Jan 14, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new device called the NSite, which is designed to help monitor scoliosis, a condition where the spine curves abnormally. The trial will involve 13 patients aged between 10 and 18 years old who are being evaluated for adolescent idiopathic scoliosis, which means the cause of their scoliosis is unknown. During the study, each patient will be scanned three times by different users to see if the device produces consistent results, helping to ensure its reliability.

To participate, patients must be between 10 and 18 years old and have been referred for evaluation or diagnosed with adolescent idiopathic scoliosis. Unfortunately, if scoliosis is caused by another condition, or if a parent or guardian cannot give consent, they will not be eligible. Participants can expect to undergo a series of scans using the NSite device, which is still being tested, and their results will contribute to the development of the device for future use. The study is currently recruiting participants, and it aims to gather important data to support the device's approval for wider use.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ages 10 and 18 years old
  • Referred for evaluation of or diagnosed of adolescent idiopathic scoliosis
  • Exclusion Criteria:
  • Scoliosis caused by another condition (e.g., secondary scoliosis)
  • Parents/guardians unable to consent
  • English is not the primary language (to avoid miscommunication)

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Palo Alto, California, United States

Patients applied

0 patients applied

Trial Officials

Kali Tileston, MD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials